http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101933742-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2012-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101933742-B1 |
| titleOfInvention | A new classifier for the molecular classification of multiple myeloma |
| abstract | The present invention relates to a method of classifying samples obtained from patients diagnosed with multiple myeloma into three newly defined clusters in the field of molecular diagnostics. The present invention also relates to a method for determining the prognosis of individuals diagnosed with multiple myeloma and a method for predicting response to treatment of individuals diagnosed with multiple myeloma. More specifically, the present invention provides a method for determining the disease outcome or prognosis of a patient diagnosed with multiple myeloma by classifying the patient into a high risk or low risk category based on the 92 gene classifier. |
| priorityDate | 2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.